Increase in the basal tone of guinea pig thoracic aorta induced by ouabain is inhibited by spironolactone canrenone and potassium canrenoate

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 4, 1996, Pages 519-525

  Sorrentino, R ^a   Cirino, G ^a   Calignano, A ^a   Mancuso, F ^a   Sorrentino, L ^a   Andriuoli, G ^b   Pinto, A ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Nordmark Farmaceutici Spa   (Italy)

^c Dept of Experimental Pharmacology ^*  (Italy)

Author keywords

Aldosterone; Canrenone; Hydrocortisone; Ouabain; Potassium canrenoate; Spironolactone

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; CALCIUM; CANRENOATE POTASSIUM; CANRENONE; HYDROCORTISONE; OUABAIN; PHENYLEPHRINE; POTASSIUM; SPIRONOLACTONE;

ANIMAL TISSUE; ARTERY TONE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL; THORACIC AORTA; VASCULAR RING;

ANIMALS; AORTA, THORACIC; CANRENOATE POTASSIUM; CANRENONE; CARDIOTONIC AGENTS; GUINEA PIGS; ISOTONIC SOLUTIONS; MUSCLE, SMOOTH, VASCULAR; NA(+)-K(+)-EXCHANGING ATPASE; OUABAIN; POTASSIUM; SPIRONOLACTONE; VASOCONSTRICTION;

EID: 0029740141     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199610000-00007     Document Type: Article

References (31)

1. Fries ED. How diuretics lower blood pressure, Am Heart J 1983;106:185-7.
2. Imbs JL, Schmidt M, Giesen-Crouze EM. Pharmacology of loop diuretics: state of art. In: Grunfeld JP, Maxwell MH, Bach JF, Crosnier J, Funck Brentano JL, eds. Advances in nephrology. Chicago: Year Book Medical, 1987;16:137-68.
3. Weber MA, Purdy RE, Drayer JIM. Interactions of mineralcorticoids and pressor agents in vascular smooth muscle. Hypertension 1983;7:41-46.
4. Beerman B, Groschinsky-Grind M. Clinical pharmacokinetics of diuretics. Clin Pharmacokinet 1980;5:221-45.
5. Wehling M, Christ M, Gerzer R. Aldosterone-specific membrane receptors and related rapid, non-genomic effects. Trends Pharmacol Sci 1993;14:1-4.
6. Ferrari P, Ferrandi M, Torrielli L, Canessa M, Bianchi G. Relationship between erythrocyte volume and sodium transport in the Milan hypertensive rat and age dependent changes. J Hypertens 1987;5:199-204.
7. Yamori Y. Physiopathology of the various spontaneously hypertensive rats. In: Genest J, Kuchel O, Hamet P, Cantin M, eds. Hypertension: physiopathology and treatment. New York: McGraw-Hill, 1977:556-81.
8. Marver D, Kokko JP. Renal target sites and the mechanism of action of aldosterone. Miner Electrolyte Metab 1983;9:1-18.
9. Erdmann E. Cell membrane receptors for cardiac glycosides in the heart. Basic Res Cardiol 1977;72:315-25.
10. Yeh BK, Sung PK. Prevention and abolition of ouabain-induced ventricular tachycardia by potassium canrenoate in dogs. Eur J Pharmacol 1972;31:18-25.
11. Yeh BK, Chiang BN, Sung PK. Antiarrhythmic activity of potassium canrenoate in man. Am J Heart 1976;92:308-14.
12. Gruber KA, Whitaker JM, Buckalev VH. Endogenous digitalis-like substance in plasma volume-expanded dogs. Nature 1980;287:743-45.
13. Gruber KA, Rudel LL, Bullock BC. Increased circulating levels of an endogenous digoxin-like factor in hypertensive monkeys. Hypertension 1982;4:348-54.
14. Deray G, Rieu M, Devynck MA, et al. Evidence for an endogenous digitalis-like factor in the plasma of patients with acromegaly, N Engl J Med 1987;316:575-80.
15. Moreth K, Renner D, Schoner W. A quantitative receptor assay for digitalis-like compounds in serum demonstration of raised concentrations in essential hypertension and correlation with arterial pressure. Klin Wochenschr 1987;65:179-84.
16. Blaustein MP, Bova S, Yuan X-Y, Goldman WF. The role of sodium/calcium exchange in the regulation of vascular contractility. In: Datsu T, Bronner F, eds. Calcium transport and intracellular calcium homeostasis. Berlin: Springer-Verlag, 1990:123-32.
17. ++ transient and contraction in vascular smooth muscle. Am J Physiol 1990;259:H409-23.
18. Hamlyn JM, Blaustein MP, Bova S, et al. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA 1991;88:6259-63.
19. Bova S, Rossi GP, Luciani S, Debetto P, Pessina AC, Cargnelli G. Effect of subthreshold ouabain on the tone of guinea-pig aortic strips following repeated noradrenaline stimulation. Br J Pharmacol 1994;111:1067-72.
20. + pump in human red blood cells. Naunyn Schmiedebergs Arch Pharmacol 1985;329:311-5.
21. Semplicini A, Buzzacarini F, Ceolotto G, et al. Effects of canrenoate on red cell sodium transport and calf flow in essential hypertension. Am J Hypertens 1993;6:295-301.
22. ++ exchange and tension development in vascular smooth muscle: effect of amiloride. Br J Pharmacol 1988;93:601-8.
23. Woolfson RG, Hilton PJ, Poston L. Effects of ouabain and low sodium on contractility of human subcutaneous resistance arteries. Hypertension 1990;15:583-90.
24. Coraboeuf E, Deroubaix E. Effect of a spironolactone derivative, sodium canrenoate, on mechanical and electrical activities of isolated rat myocardium. J Pharmacol Exp Ther 1974;191:128-38.
25. Brender D, Vanhoutte PM, Shepherd JT. Potentiation of adrenergic venomotor responses in dogs by cardiac glycosides. Cir Res 1969;25:597-606.
26. Bova S, Balustein MP, Ludens JH, Harris DW, DuCharme DW, Hamlyn JM. Effect of an endogenous ouabain-like compound on heart and aorta. Hypertension 1991;17:944-50.
27. Hamlyn JM, Manunta P. Ouabain, digitalis-like factors and hypertension. J Hypertens 1992;10:S100-11.
28. Ferrandi M, Minotti E, Salardi S, Florio M, Bianchi G, Ferrari P. Ouabain-like factor in Milan hypertensive rats. Am J Physiol 1992;263:F739-48.
29. Pamnani MB, Whitehorn WV, Clough DL, Haddy FJ. Effect of canrenone on blood pressure in rats with reduced renal mass. Am J Hypertens 1990;3:188-95.
30. Vargas F, Haro JM, Jodar E, Soler E, Garcia del Rio C. Effects of K-canrenoate on the development of DOCA-salt hypertension. J Pharm Pharmacol 1988;41:335-40.
31. Glorioso N, Tonolo G, Troffa C, et al. Recognition of markers of response to potassium canrenoate in essential hypertension. Steroids 1995;60:105-9.